Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5-Fluorouracil

• ISHIKAWA Yoichiro

  Department of Surgery, School of Medicine, Keio University

• KUBOTA Tetsuro

  Department of Surgery, School of Medicine, Keio University

• OTANI Yoshihide

  Department of Surgery, School of Medicine, Keio University

• WATANABE Masahiko

  Department of Surgery, School of Medicine, Keio University

• TERAMOTO Tatsuo

  Department of Surgery, School of Medicine, Keio University

• KUMAI Koichiro

  Department of Surgery, School of Medicine, Keio University

• TAKECHI Teiji

  Cancer Research Labararary, Taiho Pharmaceutical Co., Ltd.

• OKABE Hiroyuki

  Cancer Research Labararary, Taiho Pharmaceutical Co., Ltd.

• FUKUSHIMA Masakazu

  Cancer Research Labararary, Taiho Pharmaceutical Co., Ltd.

• KITAJIMA Masaki

  Department of Surgery, School of Medicine, Keio University

Journal

• Jpn. J. Cancer Res.

  Jpn. J. Cancer Res. 91 (1), 105-112, 2000-01-31

Keywords

• Thymidylate synthetase levels
• Dihydropyrimidine dehydrogenase levels
• Antitumor activity
• 5-Fluorouracil
• Human gastric cancer

Details

• CRID: 1571417124635268736
• NII Article ID: 10008055343
• NII Book ID: AA00690844
• ISSN: 09105050
• Web Site: https://search.jamas.or.jp/link/ui/2000143380
• Text Lang: en
• Data Source:
  • CiNii Articles